Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An Update
Mahendra Pal, Gemechu Berhanu, Chaltu Desalegn, et al.
Cureus (2020)
Open Access | Times Cited: 794

Showing 26-50 of 794 citing articles:

Knowledge, attitudes and practices associated with the COVID-19 among slum dwellers resided in Dhaka City: a Bangladeshi interview-based survey
Md. Saiful Islam, Md. Galib Ishraq Emran, Md. Estiar Rahman, et al.
Journal of Public Health (2020) Vol. 43, Iss. 1, pp. 13-25
Open Access | Times Cited: 84
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach
Md. Sorwer Alam Parvez, Md. Adnan Karim, Mahmudul Hasan, et al.
International Journal of Biological Macromolecules (2020) Vol. 163, pp. 1787-1797
Open Access | Times Cited: 82
Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota
Dan Cristian Vodnar, Laura Mitrea, Bernadette-Emőke Teleky, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 82
Addressing Africa’s pandemic puzzle: Perspectives on COVID-19 transmission and mortality in sub-Saharan Africa
Hassan Hussein Musa, Taha Hussein Musa, Idriss Hussein Musa, et al.
International Journal of Infectious Diseases (2020) Vol. 102, pp. 483-488
Open Access | Times Cited: 77
UVC disinfects SARS-CoV-2 by induction of viral genome damage without apparent effects on viral morphology and proteins
Chieh-Wen Lo, Ryosuke Matsuura, Kazuki Iimura, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 75
SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein
Ryosuke Matsuura, Chieh-Wen Lo, Satoshi Wada, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 942-942
Open Access | Times Cited: 72
Current understanding of the influence of environmental factors on SARS-CoV-2 transmission, persistence, and infectivity
Sanjeev Kumar, Ritu Singh, Nisha Kumari, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 6, pp. 6267-6288
Open Access | Times Cited: 71
Relationship between blood group and risk of infection and death in COVID-19: a live meta-analysis
Fatemeh Pourali, Mahdi Afshari, Reza Alizadeh‐Navaei, et al.
New Microbes and New Infections (2020) Vol. 37, pp. 100743-100743
Open Access | Times Cited: 69
COVID-19 Diagnosis: A Comprehensive Review of the RT-qPCR Method for Detection of SARS-CoV-2
Debashis Dutta, Sarah Naiyer, Sabanaz Mansuri, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1503-1503
Open Access | Times Cited: 64
Evaluation of certain medicinal plants compounds as new potential inhibitors of novel corona virus (COVID-19) using molecular docking analysis
Ayat Ahmed Alrasheid, Mazin Yousif Babiker, Talal Ahmed Awad
In Silico Pharmacology (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 63
Predictive modeling and therapeutic repurposing of natural compounds against the receptor-binding domain of SARS-CoV-2
Manoj Kumar Yadav, Shaban Ahmad, Khalid Raza, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 5, pp. 1527-1539
Closed Access | Times Cited: 59
Anti-viral triterpenes: a review
Priya Darshani, Shreya Sen Sarma, Amit Kumar Srivastava, et al.
Phytochemistry Reviews (2022) Vol. 21, Iss. 6, pp. 1761-1842
Open Access | Times Cited: 52
In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2
Norah A. Alturki, Mutaib M. Mashraqi, Ahmad Alzamami, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4391-4391
Open Access | Times Cited: 52
Therapeutic monoclonal antibodies for COVID-19 management: an update
Vivek P. Chavda, Riddhi Prajapati, Disha Lathigara, et al.
Expert Opinion on Biological Therapy (2022) Vol. 22, Iss. 6, pp. 763-780
Closed Access | Times Cited: 51
SARS-CoV-2 E484K Mutation Narrative Review: Epidemiology, Immune Escape, Clinical Implications, and Future Considerations
Wanting Yang, Wei-Hsuan Huang, Tsai‐Ling Liao, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 373-385
Open Access | Times Cited: 43
Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
Lara Alzyoud, Mohammad A. Ghattas, Noor Atatreh
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 2463-2478
Open Access | Times Cited: 40
Four Types of Multiclass Frameworks for Pneumonia Classification and Its Validation in X-ray Scans Using Seven Types of Deep Learning Artificial Intelligence Models
Nillmani, Pankaj K. Jain, Neeraj Sharma, et al.
Diagnostics (2022) Vol. 12, Iss. 3, pp. 652-652
Open Access | Times Cited: 39
Neurological manifestations in patients with COVID‐19: A systematic review and meta‐analysis
Marzie Mahdizade Ari, Mohamad Hosein Mohamadi, Negar Shadab Mehr, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 5
Open Access | Times Cited: 39
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
Rebar N. Mohammed, Rozita Tamjidifar, Heshu Sulaiman Rahman, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Quercetin: A Functional Food-Flavonoid Incredibly Attenuates Emerging and Re-Emerging Viral Infections through Immunomodulatory Actions
Fauzia Mahanaz Shorobi, Fatema Yasmin Nisa, Srabonti Saha, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 938-938
Open Access | Times Cited: 36
Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential
Arafa Musa, Hamada S. Abulkhair, Ateyatallah Aljuhani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 463-463
Open Access | Times Cited: 35
New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
Raghu Solanki, Abhishek Shankar, Unnati Modi, et al.
Materials Today Chemistry (2023) Vol. 29, pp. 101478-101478
Open Access | Times Cited: 32
Omicron Variant of SARS-CoV-2: An Indian Perspective of Vaccination and Management
Vivek P. Chavda, Pankti C. Balar, Dixa A. Vaghela, et al.
Vaccines (2023) Vol. 11, Iss. 1, pp. 160-160
Open Access | Times Cited: 28
Viral Infections, Are They a Trigger and Risk Factor of Alzheimer’s Disease?
Meagan D. Rippee‐Brooks, Wenzhe Wu, Jianli Dong, et al.
Pathogens (2024) Vol. 13, Iss. 3, pp. 240-240
Open Access | Times Cited: 11
Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments
Emina Karahmet Sher, Mirna Alebić, Marijana Marković Boras, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124345-124345
Open Access | Times Cited: 11

Scroll to top